Aims and Scope
Mathews Journal of Cancer Science (ISSN 2474-6797) — is an open access journal publishes original studies and reports, which provide significance and board impact on a wider audience. The main scope of the journal is in its primary sections of preclinical, clinical, epidemiological, treatments of different cancer, Cancer Biology, lymphoma, sarcoma, cancer genetics, cancer therapy, gynecologic cancer, brain tumor, malignant tumor, lung cancer, cancer prevention & epidemiology, oncogene study and benign tumors.
Editors and Editorial Board
Editorial process of cancer science journal and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board and journal staff.
Mathews Journal of Cancer Science (MJCS) Print ISSN: 2474-6797 and Online ISSN: 2474-6797 is published Bimonthly, a Volume/year.
Benefits of authors
High Visibility: Mathews Journal of Cancer Science (MJCS) as per open access policy allows maximum visibility of articles published in the journal available across the globe.
Promotion in Social Media: Once the article is published, we provide article alerts and regular email updates to subscribers on our social media platforms.
Speed Publication: Mathews Journal of Cancer Science (MJCS) provides fast publication of the submitted articles with quality review process with the esteem editorial board team and reviewer’s team.
If you are not sure whether your work suitable for this journal, please email us at email@example.com or call us at (Toll-Free) +1 800 369 0052.
Published : 17th June 2019
Authors : Reger R. Mikaeel1,2,3,4 , Timothy J. Price1,3, Eric Smith1,5, Paul A. Drew5, Wendy Uylaki1,6, Mehgan Horsnell1, Joanne P. Young1,2,3
Citation : Mikaeel RR. (2019). Colorectal Cancer in Australian Young Adults. Mathews J Cancer Sci. 4(1): 18
Published : 17th March 2019
Authors : Jiancang Wang*, Feifan Du, Ming Su, Xiting Guo, Haixia Tian, Yanxia Song, Liya shang, Wei Zheng, Xiaoge Yang
Citation : Wang J (2019). Cytomegalovirus Retinitis in a 4-Year-Old Child with Acute Lymphoblastic Leukemia: Treatment and Prognosis. MJC (4) 1: 17
Published : 30th November 2018
Authors : Yang Yang1,3, Olagoke Zacchaeus Olatunde2 , Jianping Yong1 *, Canzhong Lu1,2*
Citation : Yang Y, Olatunde OZ, Yong J and Lu C. (2018). Progress of Chemical Components and Biological Activities of Lonicera Maackii. Mathews J Cancer Sci. 3(1): 016.
Published : 12th November 2018
Authors : Mahdis Solhjoo1*,Alireza Rastgoo Haghi2,Nasim Golchin3,Negar Golchin4,Roham Shahbazi2
Citation : Solhjoo M, Haghi AR, Golchin N, Golchin N, et al. (2018). Expression of E-cadherin and Ki-67 in Gastric Cancer Patients and Cor- relation with Clinicopathological Factors.Mathews J Cancer Sci. 3(1): 015
Published : 18th September 2018
Author : Jussara Maria Gonçalves1 *
Citation : Gonçalves JM. (2018). Cancer Stem Cells: Current Challenge in Cancer Treatment and Important Prognosis Factor.Mathews J Cancer Sci. 3(1): e001
Published : 26th February 2018
Author : Dennis Stamp1*
Citation : Stamp D. (2018). Suggested Model to Induce Esophageal Cancer and Its Precursor Lesions in the Esophagus of Rats. Mathews J Cancer Sci. 3(1): 014.
Published : 27th April 2017
Author : Daniela Capdepón*
Citation : Capdepón D. (2017). Advances in the Care of Diabetes and Cancer. Mathews J Cancer Sci. 2(1): 013.
Published : 01st March 2017
Authors : Aurelio B. Castrellon*, Steven M. Nguyen, Adriana M. Milillo Naraine, Michel Velez, Luis E. Raez
Citation : Castrellon AB, Nguyen SM, Milillo Naraine AM, Velez M, et al. (2017). Initial Response to Therapy with Fulvestrant and Cyclin-Dependent Kinase 4/6 Inhibitor in a Male with Stage IV Breast Cancer.Mathews J Cancer Sci. 2(1): 012.
Published : 21st February 2017
Authors : Siva Narayanan*, Smeet Gala
Citation : Narayanan S and Gala S. (2017). Burden of Merkel Cell Carcinoma: A Targeted Literature Review. Mathews J Cancer Sci. 2(1): 011.